Dexcom(DE:DC4)
€71.80+0.40 (+0.56%)
DE:DC4
Dexcom stock forecast
€71.80
At close:+0.40 (+0.56%)
Dexcom (DC4) Stock Forecast & Price Target
4 Followers
DC4 Analyst Ratings
Strong Buy
16Buy1Hold0Sell
Based on 17 analysts giving stock ratings to Dexcom in the past 3 months
DC4 Stock 12 Month Forecast
Average Price Target
€88.47▲(23.21% Upside)Based on 17 Wall Street analysts offering 12 month price targets for Dexcom in the last 3 months. The average price target is EUR 88.47 with a high forecast of EUR 106.62 and a low forecast of EUR 75.53. The average price target represents a 23.21% change from the last price of EUR 71.80.
Past 12 Months12 Month ForecastJan2026Oct2026
High€106.62
Average€88.47
Low€75.53
Highest Price TargetHighest€106.62Average Price Target€88.47Lowest Price TargetLowest€75.53
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | Leerink Partners | €77.30→€83.52 | buy | 16.33%Upside | Reiterated | 11/02/26 | ||
| Christopher Pasquale | Barclays | €102.18→€106.62 | buy | 48.50%Upside | Reiterated | 10/30/26 | ||
| William Plovanic | Canaccord Genuity | €79.97→€86.19 | buy | 20.04%Upside | Reiterated | 10/30/26 | ||
| Matthew O'Brien | Piper Sandler | €84.41 | buy | 17.56%Upside | Reiterated | 10/30/26 | ||
| Patrick Wood | UBS | €90.63→€95.07 | buy | 32.41%Upside | Assigned | 10/30/26 | ||
| Unknown AnalystNot Ranked | Evercore ISI | €97.74 | buy | 36.13%Upside | Reiterated | 10/30/26 | ||
| Jonathan Block | Stifel Nicolaus | €84.41 | buy | 17.56%Upside | Reiterated | 10/30/26 | ||
| Josh Jennings | TD Cowen | €84.41 | buy | 17.56%Upside | Reiterated | 10/30/26 | ||
| Jayson Bedford | Raymond James | €83.52→€86.19 | buy | 20.04%Upside | Reiterated | 10/30/26 | ||
| Robbie Marcus | J.P. Morgan | €72.86→€75.53 | hold | 5.19%Upside | Assigned | 10/30/26 | ||
| Kendall Au | RBC Capital | €93.30 | buy | 29.94%Upside | Reiterated | 10/29/26 | ||
| Travis Steed | Bank of America Securities | ― | buy | ― | Reiterated | 10/23/26 | ||
| Joanne Wuensch | Citi | €93.30 | buy | 29.94%Upside | Reiterated | 10/21/26 | ||
| Larry Biegelsen | Wells Fargo | €79.97 | buy | 11.38%Upside | Reiterated | 10/14/26 | ||
| Anthony Petrone | Mizuho Securities | €84.41→€88.85 | buy | 23.75%Upside | Assigned | 10/13/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Unknown AnalystLeerink PartnersNot Ranked | BuyReiterated€77.30→€83.52 | 11/02/26 | 16.33%Upside | ||
| Christopher PasqualeBarclays | BuyReiterated€102.18→€106.62 | 10/30/26 | 48.50%Upside | ||
| William PlovanicCanaccord Genuity | BuyReiterated€79.97→€86.19 | 10/30/26 | 20.04%Upside | ||
| Matthew O'BrienPiper Sandler | BuyReiterated€84.41 | 10/30/26 | 17.56%Upside | ||
| Patrick WoodUBS | BuyAssigned€90.63→€95.07 | 10/30/26 | 32.41%Upside | ||
| Unknown AnalystEvercore ISINot Ranked | BuyReiterated€97.74 | 10/30/26 | 36.13%Upside | ||
| Jonathan BlockStifel Nicolaus | BuyReiterated€84.41 | 10/30/26 | 17.56%Upside | ||
| Josh JenningsTD Cowen | BuyReiterated€84.41 | 10/30/26 | 17.56%Upside | ||
| Jayson BedfordRaymond James | BuyReiterated€83.52→€86.19 | 10/30/26 | 20.04%Upside | ||
| Robbie MarcusJ.P. Morgan | HoldAssigned€72.86→€75.53 | 10/30/26 | 5.19%Upside | ||
| Kendall AuRBC Capital | BuyReiterated€93.30 | 10/29/26 | 29.94%Upside | ||
| Travis SteedBank of America Securities | BuyReiterated | 10/23/26 | ― | ||
| Joanne WuenschCiti | BuyReiterated€93.30 | 10/21/26 | 29.94%Upside | ||
| Larry BiegelsenWells Fargo | BuyReiterated€79.97 | 10/14/26 | 11.38%Upside | ||
| Anthony PetroneMizuho Securities | BuyAssigned€84.41→€88.85 | 10/13/26 | 23.75%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Dexcom
3 Months
Success Rate27/43 ratings generated profit
63%
Average Return
+9.95%
Copying Jeff Johnson's trades and holding each position for 3 Months would result in 62.79% of your transactions generating a profit, with an average return of +9.95% per trade.
1 Year
Success Rate35/50 ratings generated profit
70%
Average Return
+36.00%
Copying Steven Lichtman's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +36.00% per trade.
2 Years
Success Rate38/50 ratings generated profit
76%
Average Return
+83.55%
Copying Steven Lichtman's trades and holding each position for 2 Years would result in 76.00% of your transactions generating a profit, with an average return of +83.55% per trade.
DC4 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 3 | 0 | 0 | 0 | 0 |
| Buy | 64 | 38 | 32 | 28 | 25 |
| Hold | 2 | 2 | 2 | 2 | 1 |
| Sell | 2 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 71 | 40 | 34 | 30 | 26 |
In the current month, DC4 has received 25 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. DC4 average Analyst price target in the past 3 months is 88.47.
DC4 Financial Forecast
High€0.69
Consensus€0.64
Low€0.60
DC4 Earnings Forecast
Next quarter’s earnings estimate for DC4 is EUR 0.64 with a range of EUR 0.60 to EUR 0.69. The previous quarter’s EPS was EUR 0.65. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High€1.25B
Consensus€1.23B
Low€1.21B
DC4 Sales Forecast
Next quarter’s sales forecast for DC4 is EUR 1.23B with a range of EUR 1.21B to EUR 1.25B. The previous quarter’s sales results were EUR 1.20B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
DC4 Stock Forecast FAQ
What is DE:DC4’s average 12-month price target, according to analysts?
Based on analyst ratings, Dexcom’s 12-month average price target is €88.47.
What is DE:DC4’s upside potential, based on the analysts’ average price target?
Dexcom has 23.21% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Dexcom a Buy, Sell or Hold?
Dexcom has a consensus rating of Strong Buy, which is based on 16 buy ratings, 1 hold ratings and 0 sell ratings.
What is Dexcom’s share price target?
The average share price target for Dexcom is €88.47. This is based on 17 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €106.62, and the lowest forecast is €75.53. The average share price target represents a 23.21% increase from the current price of €71.8.
What do analysts say about Dexcom?
Dexcom’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Street analysts.
How can I buy shares of Dexcom?
To buy shares of DE:DC4, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
